AU2021903722A0 - Peptides and Uses Thereof - Google Patents

Peptides and Uses Thereof

Info

Publication number
AU2021903722A0
AU2021903722A0 AU2021903722A AU2021903722A AU2021903722A0 AU 2021903722 A0 AU2021903722 A0 AU 2021903722A0 AU 2021903722 A AU2021903722 A AU 2021903722A AU 2021903722 A AU2021903722 A AU 2021903722A AU 2021903722 A0 AU2021903722 A0 AU 2021903722A0
Authority
AU
Australia
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021903722A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Preveceutical Medical Inc
Original Assignee
Preveceutical Medical Inc
Filing date
Publication date
Application filed by Preveceutical Medical Inc filed Critical Preveceutical Medical Inc
Publication of AU2021903722A0 publication Critical patent/AU2021903722A0/en
Priority to PCT/IB2022/061117 priority Critical patent/WO2023089542A1/en
Priority to CA3238696A priority patent/CA3238696A1/en
Pending legal-status Critical Current

Links

AU2021903722A 2021-11-18 2021-11-18 Peptides and Uses Thereof Pending AU2021903722A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2022/061117 WO2023089542A1 (en) 2021-11-18 2022-11-18 Peptides and uses thereof
CA3238696A CA3238696A1 (en) 2021-11-18 2022-11-18 Peptides and uses thereof

Publications (1)

Publication Number Publication Date
AU2021903722A0 true AU2021903722A0 (en) 2021-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3737399A4 (en) Atf5 peptide variants and uses thereof
EP3740228A4 (en) Peptides and uses thereof
EP3909975A4 (en) Novel polypeptide and therapeutic uses thereof
EP3882263A4 (en) Glucagon-derived peptide and use thereof
EP4003391A4 (en) Peptides and methods of using the same
AU2020234373A1 (en) Novel peptide and use thereof
EP4004021A4 (en) Polypeptides having anti-senescent effects and uses thereof
EP3952988A4 (en) Aav-cas13d vectors and uses thereof
EP3966231A4 (en) Factor h vectors and uses thereof
EP3996737A4 (en) Peptides and uses thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
EP3984595A4 (en) Peptide and use thereof
EP4023663A4 (en) Polypeptide and application thereof
AU2021903722A0 (en) Peptides and Uses Thereof
AU2020904544A0 (en) Peptides and uses thereof
AU2020904375A0 (en) Peptides and uses thereof
AU2020902233A0 (en) Peptides and uses thereof
EP3932912A4 (en) Protein and/or peptide modification molecule
EP3774848A4 (en) Cyclic peptides and uses thereof
AU2019902437A0 (en) Peptides and uses thereof
AU2019902436A0 (en) Peptides and uses thereof
EP3908307A4 (en) Novel peptides and uses thereof
AU2021900769A0 (en) Proteins and uses thereof
AU2020904798A0 (en) Cyclic Peptides and Uses Thereof
AU2021901193A0 (en) Modified polypeptides and uses thereof